Accustem Sciences ACUT
OTC ACUT
$0.14 +0.02 (+16.67%)
At close: Sep 29, 2026 · 4:00 PM EDT

Accustem Sciences (ACUT) Return on Equity [ROE] (2021 - 2022)

Updated

Accustem Sciences' Return on Equity [ROE] came in at -1138.43% for Q4 2022, down 1065.54 percentage points from -72.89% a year earlier and down 867.92 percentage points from the prior quarter.

Analysis

Accustem Sciences (ACUT) Return on Equity [ROE] (2021 - 2022) Analysis & Trends

For FY2022, Accustem Sciences' Return on Equity [ROE] was -1465.96%.

  • Business Quant data shows ACUT's Return on Equity [ROE] at -270.50% (Q3 2022), -114.01% (Q2 2022) and -86.62% (Q1 2022) in the three quarters before Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 HCA Healthcare 93.06 Bn 92.50 Bn - -
2 Natera 59.36 Bn 55.04 Bn 485.19 Mn -10.70%
3 Quest Diagnostics 25.72 Bn 24.15 Bn 1.03 Bn 14.38%
4 Labcorp Holdings 24.93 Bn 22.69 Bn 1.11 Bn 11.58%
5 Guardant Health 23.83 Bn 19.89 Bn 219.03 Mn -
6 Tenet Healthcare 20.58 Bn 11.72 Bn - 47.84%
7 Tempus AI 14.35 Bn 11.38 Bn 246.50 Mn -57.32%
8 Encompass Health 11.99 Bn 12.46 Bn - 24.83%
9 BrightSpring Health Services 11.21 Bn 9.55 Bn 492.75 Mn 18.16%
10 Accustem Sciences 2.25 Mn 2.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -1,138.43%
Sep 30, 2022 -270.50%
Jun 30, 2022 -114.01%
Mar 31, 2022 -86.62%
Dec 31, 2021 -72.89%
API Access

Accustem Sciences Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ACUT&period=max&api_key=YOUR_API_KEY